Cigna Investments Inc Bristol Myers Squibb CO Transaction History

Cigna Investments Inc

  • $573 Million
  • Q4 2024

A detailed history of Cigna Investments Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Cigna Investments Inc holds 20,781 shares of BMY stock, worth $1.27 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
20,781
Previous 20,906 0.6%
Holding current value
$1.27 Million
Previous $1.08 Million 8.69%
% of portfolio
0.21%
Previous 0.19%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 29, 2025
SELL
$51.92 - $59.94 $6,490 - $7,492
-125 Reduced 0.6%
20,781 $1.18 Million
Q3 2024

Oct 28, 2024
SELL
$39.66 - $51.75 $18,283 - $23,856
-461 Reduced 2.16%
20,906 $1.08 Million
Q2 2024

Jul 17, 2024
SELL
$40.25 - $52.99 $5,836 - $7,683
-145 Reduced 0.67%
21,367 $888,000
Q1 2024

Apr 23, 2024
SELL
$47.98 - $54.4 $12,906 - $14,633
-269 Reduced 1.24%
21,512 $1.17 Million
Q4 2023

Jan 22, 2024
SELL
$48.48 - $57.85 $33,111 - $39,511
-683 Reduced 3.04%
21,781 $1.12 Million
Q3 2023

Oct 23, 2023
SELL
$57.89 - $64.73 $176,390 - $197,232
-3,047 Reduced 11.94%
22,464 $1.3 Million
Q2 2023

Aug 01, 2023
SELL
$63.71 - $70.74 $22,617 - $25,112
-355 Reduced 1.37%
25,511 $1.63 Million
Q1 2023

May 11, 2023
SELL
$65.71 - $74.53 $33,709 - $38,233
-513 Reduced 1.94%
25,866 $1.79 Million
Q4 2022

Feb 13, 2023
BUY
$68.48 - $81.09 $9,655 - $11,433
141 Added 0.54%
26,379 $1.9 Million
Q3 2022

Nov 14, 2022
SELL
$0.13 - $76.84 $189 - $111,955
-1,457 Reduced 5.26%
26,238 $1.87 Million
Q2 2022

Aug 15, 2022
SELL
$72.62 - $79.98 $831,571 - $915,850
-11,451 Reduced 29.25%
27,695 $2.13 Million
Q1 2022

May 13, 2022
SELL
$61.48 - $73.72 $704,683 - $844,978
-11,462 Reduced 22.65%
39,146 $2.86 Million
Q4 2021

Feb 14, 2022
SELL
$53.63 - $62.52 $946,623 - $1.1 Million
-17,651 Reduced 25.86%
50,608 $3.16 Million
Q3 2021

Nov 12, 2021
SELL
$59.17 - $69.31 $91,476 - $107,153
-1,546 Reduced 2.21%
68,259 $4.04 Million
Q2 2021

Aug 10, 2021
SELL
$61.91 - $67.42 $682,248 - $742,968
-11,020 Reduced 13.63%
69,805 $4.67 Million
Q1 2021

May 10, 2021
BUY
$59.34 - $66.74 $101,590 - $114,258
1,712 Added 2.16%
80,825 $5.1 Million
Q4 2020

Feb 11, 2021
BUY
$57.74 - $65.43 $347,190 - $393,430
6,013 Added 8.23%
79,113 $4.91 Million
Q3 2020

Nov 12, 2020
SELL
$57.43 - $63.64 $197,903 - $219,303
-3,446 Reduced 4.5%
73,100 $4.41 Million
Q2 2020

Aug 17, 2020
BUY
$54.82 - $64.09 $557,190 - $651,410
10,164 Added 15.31%
76,546 $4.5 Million
Q1 2020

May 11, 2020
BUY
$46.4 - $67.43 $49,972 - $72,622
1,077 Added 1.65%
66,382 $3.7 Million
Q4 2019

Feb 04, 2020
BUY
$49.21 - $64.19 $850,742 - $1.11 Million
17,288 Added 36.0%
65,305 $4.11 Million
Q3 2019

Nov 07, 2019
BUY
$42.77 - $50.71 $103,375 - $122,566
2,417 Added 5.3%
48,017 $2.76 Million
Q2 2019

Aug 12, 2019
SELL
$44.62 - $49.34 $66,930 - $74,010
-1,500 Reduced 3.18%
45,600 $2.03 Million
Q1 2019

May 10, 2019
SELL
$45.12 - $53.8 $150,294 - $179,207
-3,331 Reduced 6.61%
47,100 $2.25 Million
Q4 2018

Feb 06, 2019
BUY
$48.76 - $63.23 $54,806 - $71,070
1,124 Added 2.28%
50,431 $2.62 Million
Q3 2018

Nov 13, 2018
SELL
$55.19 - $62.25 $887,896 - $1 Million
-16,088 Reduced 24.6%
49,307 $2.49 Million
Q2 2018

Aug 14, 2018
SELL
$50.53 - $62.98 $402,370 - $501,509
-7,963 Reduced 10.85%
65,395 $3.62 Million
Q1 2018

May 09, 2018
SELL
$59.92 - $68.98 $42,663 - $49,113
-712 Reduced 0.96%
73,358 $4.64 Million
Q4 2017

Jan 26, 2018
SELL
$59.94 - $65.35 $157,522 - $171,739
-2,628 Reduced 3.43%
74,070 $4.54 Million
Q3 2017

Oct 11, 2017
BUY
$55.23 - $63.74 $4.24 Million - $4.89 Million
76,698
76,698 $4.89 Million

Others Institutions Holding BMY

# of Institutions
2,761
Shares Held
1.57B
Call Options Held
28M
Put Options Held
28.7M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $130B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Cigna Investments Inc Portfolio

Follow Cigna Investments Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cigna Investments Inc , based on Form 13F filings with the SEC.

News

Stay updated on Cigna Investments Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email